References
- WHO. 'Global health sector strategy on viral hepatitis 2016 to 2021: towards ending viral hepatitis' 2016 [cited 20 March 2023].
- Harris HE, Costella A, Mandal S, et al. Hepatitis C in England, 2022: working to eliminate hepatitis C as a public health problem. Full report. Mar, 2022. cited 2023 Mar 25 London: UK Health Security Agency.
- Public Health England (PHE). ‘Impact of COVID-19 on STIs, HIV and viral hepatitis in England: 2020 report. [cited 2023 Mar].
- UK Health Security Agency. Hepatitis C In The UK 2023 Working To Eliminate Hepatitis C As a Public Health Threat. [cited 2023 Mar 25].
- Shiha G, Metwally AM, Soliman R, et al. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project. Lancet Gastroenterol Hepatol. 2018;3(11):778–789. doi: 10.1016/S2468-1253(18)30139-0
- Public Health England (PHE). UK Standards For Microbiology Investigations. Screening For Hepatitis C Infection 2017 [cited 2023 Mar 15].
- Phillips C, Schulkind J, O’Sullivan M, et al. Improving access to care for people who inject drugs: qualitative evaluation of project ITTREAT-An integrated community hepatitis C service. J Viral Hepat. 2020 Feb;27(2):176–187. doi: 10.1111/jvh.13214
- PHE. ‘Unlinked anonymous monitoring (UAM) survey of HIV and viral hepatitis among PWID: 2021 report preliminary data’ 2021. [cited 2023 Mar 7].
- Jugnarain DV, Halford R, Smith S, et al. Role of peer support in a hepatitis C elimination programme. J Viral Hepat. 2022 Jan;29(1):43–51. doi: 10.1111/jvh.13626
- Guerra-Veloz MF, Han K, Oakes K, et al. Results of a model of delivering hepatitis C care in a homeless metropolitan population in England. Am J Gastroenterol. 2023 Jun 1;118(6):991–1000. doi: 10.14309/ajg.0000000000002041
- Oru E, Trickey A, Shirali R, et al. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Lancet Glob Health. 2023 Apr;9(4):e431–e445. doi: 10.1016/S2214-109X(20)30505-2
- Radley A, de Bruin M, Inglis SK, et al. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. Lancet Gastroenterol Hepatol. 2020 Sep;5(9):809–818. doi: 10.1016/S2468-1253(20)30120-5
- NHS. Community Pharmacy Hepatitis C Antibody Testing Service - Advanced Service, Service Specification. Jul 2020. [cited 2023 Jul 9].